A new command center is setting out to promote the development of domestic vaccines through creation of a more supportive research and funding environment.
Takeda and Daiichi Sankyo collaborate to create wearable device pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Japan has been leveraging different policy tools to rein in drug expenditures, and that is scaring foreign pharmas away. The country is seeing “trends of a drug lag” as approvals decrease, Yasushi Okada, president of the Japan Pharmaceutical Manufacturers Association and Eisai’s chief operating officer, said.
November 19, 2021 - The Japan Times japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Background: The recent trend of pharmaceutical companies commercializing new objects as new drugs based on the findings of academic medical researchers, commonly categorizing them as “academic drug discovery” is increasingly gaining popularity in the pharmaceutical industry. Studies state that academic researchers based in universities have lower motivation to apply for patents. However, none of the studies evaluated the existence and extent of the “motivation for patent” in academic researchers, being lower than that of pharmaceutical companies. This study assesses two hypotheses; H1: academic medical researchers are less likely to believe that the patent system is necessary for pharmaceuticals, and thus have diminished interest in the commercialization of their research findings when compared to those in the pharmaceutical industry, H2: apprehension of the raison d’être of the patent system affects positive impressions on patents among academic medical researchers.